The ELEVATUM study's initial data showed vision improvements in patients who were given Vabysmo every eight weeks for a year.

According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational ...

The fight against Age Related Molecular Degeneration Market is seeing a promising boost. According to a recent analysis, the ...

According to Research by SNS Insider, Dry AMD Market Growth is Driven by New Therapies, Geriatric Population Boom, and Advancements in R&D.Pune, Oct. 17, 2024 (GLOBE NEWSWIRE) -- SNS Insider reports ...

CHICAGO, CA, UNITED STATES, October 18, 2024 /EINPresswire / -- The Global Age-Related Macular Degeneration (AMD) <a target=_blank href= ...

Our latest Mane Attraction spawned some interesting replies from both sides of the aisle…but not what the “both sides” anticipated.

The quest to find a cure for the UK’s biggest cause of sight loss will be brought sharply into focus at a support group for ...

Metformin shows promise as a potential therapy for limiting the risk of developing age-related macular degeneration.

A new study published in the Journal of American Medical Association showed that rare instances of noninfectious intraocular ...

Data about higher doses that are injected less often come as the original 2-milligram dose of Eylea is facing an increasing ...

Many people who have age-related macular degeneration don't know it. But ignoring this condition can lead to vision loss that can make it hard to perform everyday tasks. Many people who have ...